Literature DB >> 32703516

Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week.

Matthew A Nazari1, Jared S Rosenblum2, Mark C Haigney3, Douglas R Rosing4, Karel Pacak5.   

Abstract

Pheochromocytomas, arising from chromaffin cells, produce catecholamines, epinephrine and norepinephrine. The tumor biochemical phenotype is defined by which of these exerts the greatest influence on the cardiovascular system when released into circulation in high amounts. Action on the heart and vasculature can cause potentially lethal arrhythmias, often in the setting of comorbid blood pressure derangements. In a review of electrocardiograms obtained on pheochromocytoma patients (n = 650) treated at our institution over the last decade, severe and refractory sinus tachycardia, atrial fibrillation, and ventricular tachycardia were found to be the most common or life-threatening catecholamine-induced tachyarrhythmias. These arrhythmias, arising from catecholamine excess rather than from a primary electrophysiologic substrate, require special considerations for treatment and complication avoidance. Understanding the synthesis and release of catecholamines, the adrenoceptors catecholamines bind to, and the cardiac and vascular response to epinephrine and norepinephrine underlies optimal management in catecholamine-induced tachyarrhythmias.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blood pressure; catecholamines; pheochromocytoma; sinus tachycardia; tachyarrhythmias; ventricular tachycardia

Mesh:

Year:  2020        PMID: 32703516      PMCID: PMC7454044          DOI: 10.1016/j.jacc.2020.04.080

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  53 in total

Review 1.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

Review 2.  Venoarterial ECMO for Adults: JACC Scientific Expert Panel.

Authors:  Maya Guglin; Mark J Zucker; Vanessa M Bazan; Biykem Bozkurt; Aly El Banayosy; Jerry D Estep; John Gurley; Karl Nelson; Rajasekhar Malyala; Gurusher S Panjrath; Joseph B Zwischenberger; Sean P Pinney
Journal:  J Am Coll Cardiol       Date:  2019-02-19       Impact factor: 24.094

Review 3.  Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations.

Authors:  H J Motulsky; P A Insel
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

4.  2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC).

Authors:  Josep Brugada; Demosthenes G Katritsis; Elena Arbelo; Fernando Arribas; Jeroen J Bax; Carina Blomström-Lundqvist; Hugh Calkins; Domenico Corrado; Spyridon G Deftereos; Gerhard-Paul Diller; Juan J Gomez-Doblas; Bulent Gorenek; Andrew Grace; Siew Yen Ho; Juan-Carlos Kaski; Karl-Heinz Kuck; Pier David Lambiase; Frederic Sacher; Georgia Sarquella-Brugada; Piotr Suwalski; Antonio Zaza
Journal:  Eur Heart J       Date:  2020-02-01       Impact factor: 29.983

5.  Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase.

Authors:  A Sjoerdsma; K Engelman; S Spector; S Udenfriend
Journal:  Lancet       Date:  1965-11-27       Impact factor: 79.321

6.  High incidence of cardiovascular complications in pheochromocytoma.

Authors:  T Zelinka; O Petrák; H Turková; R Holaj; B Strauch; M Kršek; A B Vránková; Z Musil; J Dušková; J Kubinyi; D Michalský; K Novák; J Widimský
Journal:  Horm Metab Res       Date:  2012-04-19       Impact factor: 2.936

7.  Ivabradine in Catecholamine-Induced Tachycardia in a Patient with Paraganglioma.

Authors:  Gelinemae Malaza; Alessandra Brofferio; Frank Lin; Karel Pacak
Journal:  N Engl J Med       Date:  2019-03-28       Impact factor: 91.245

Review 8.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Hormone action at the membrane level. VIII. Adrenergic receptors in rat heart and adipocytes and their modulation by thyroxine.

Authors:  T P Ciaraldi; G V Marinetti
Journal:  Biochim Biophys Acta       Date:  1978-07-03

10.  Life-threatening events in patients with pheochromocytoma.

Authors:  Anna Riester; Dirk Weismann; Marcus Quinkler; Urs D Lichtenauer; Sandra Sommerey; Roland Halbritter; Randolph Penning; Christine Spitzweg; Jochen Schopohl; Felix Beuschlein; Martin Reincke
Journal:  Eur J Endocrinol       Date:  2015-09-07       Impact factor: 6.664

View more
  13 in total

Review 1.  Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment.

Authors:  Sara Talvacchio; Matthew A Nazari; Karel Pacak
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

Review 2.  Sinus Tachycardia: a Multidisciplinary Expert Focused Review.

Authors:  Kenneth A Mayuga; Artur Fedorowski; Fabrizio Ricci; Rakesh Gopinathannair; Jonathan Walter Dukes; Christopher Gibbons; Peter Hanna; Dan Sorajja; Mina Chung; David Benditt; Robert Sheldon; Mirna B Ayache; Hiba AbouAssi; Kalyanam Shivkumar; Blair P Grubb; Mohamed H Hamdan; Stavros Stavrakis; Tamanna Singh; Jeffrey J Goldberger; James A S Muldowney; Mark Belham; David C Kem; Cem Akin; Barbara K Bruce; Nicole E Zahka; Qi Fu; Erik H Van Iterson; Satish R Raj; Fetnat Fouad-Tarazi; David S Goldstein; Julian Stewart; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-09-08

3.  An Interesting Case of Treatment-Resistant Ventricular Tachycardia Secondary to Pheochromocytoma and Left Ventricular Non-compaction.

Authors:  Zahid Khan
Journal:  Cureus       Date:  2022-05-30

4.  The association between the type of anesthesia and hemodynamic instability during pheochromocytoma surgery: a retrospective cohort study.

Authors:  Won Woong Kim; Doo-Hwan Kim; Jae Won Cho; Cheong-Sil Rah; Yu-Mi Lee; Ki-Wook Chung; Jung-Min Koh; Seung Hun Lee; Suck Joon Hong; Yeon Ju Kim; Tae-Yon Sung
Journal:  Surg Endosc       Date:  2022-01-10       Impact factor: 3.453

Review 5.  Catecholamine physiology and its implications in patients with COVID-19.

Authors:  Sriram Gubbi; Matthew A Nazari; David Taieb; Joanna Klubo-Gwiezdzinska; Karel Pacak
Journal:  Lancet Diabetes Endocrinol       Date:  2020-10-28       Impact factor: 32.069

Review 6.  Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.

Authors:  Mickey J M Kuo; Matthew A Nazari; Abhishek Jha; Karel Pacak
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

7.  An Unusual Presentation of Paroxysmal Atrial Fibrillation Following Ablation.

Authors:  Zachary P Kerosky; Emily Strickland; Takor Arreymbi; Joel Abbott
Journal:  Cureus       Date:  2022-07-23

8.  Adrenal bleeding due to pheochromocytoma - A call for algorithm.

Authors:  Ewelina Rzepka; Joanna Kokoszka; Anna Grochowska; Magdalena Ulatowska-Białas; Martyna Lech; Marta Opalińska; Elwira Przybylik-Mazurek; Aleksandra Gilis-Januszewska; Alicja Hubalewska-Dydejczyk
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

Review 9.  Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach.

Authors:  M Araujo-Castro; E Pascual-Corrales; L Nattero Chavez; A Martínez Lorca; T Alonso-Gordoa; J Molina-Cerrillo; J Lorca Álvaro; C Mínguez Ojeda; S Redondo López; R Barberá Durbán; R Polo López; N Moreno Mata; U Caballero Silva; H Pian; I Ruz-Caracuel; A Sanjuanbenito Dehesa; V Gómez Dos Santos; A B Serrano Romero
Journal:  J Endocrinol Invest       Date:  2021-07-25       Impact factor: 4.256

Review 10.  New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.

Authors:  Martin Aguilar; Robert A Rose; Abhijit Takawale; Stanley Nattel; Svetlana Reilly
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.